SPTX

$23.28-3.24%

Seaport Therapeutics, Inc.

Market Cap

$1.2B

Sector

Materials

Industry

Pharmaceuticals

Beta

—

Insufficient price history

Price Chart

Loading…

Signals

Insider Velocity

Market & Alt Data

News

8

recent articles

Analyst Consensus

Strong Buy

13 analysts

Velocity Score

24.85x

Current Rate (90d)

12366.67/mo

Baseline Rate

0.00/mo

Unique Buyers (90d)

2

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-06-22	2026-06-24	HOMBACH ROBERT J.	Director	Purchase	13.0K	$18.14	$236K	13.0K	View
2026-05-04	2026-05-04	ARCH Venture Partners XII, LLC	10% Owner	Purchase	1.10M	$18.00	$19.80M	6.29M	View

Recent News

PureTech Founded Entity Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo™ in Healthy Volunteers

Yahoo Finance · 2026-09-09

Seaport Therapeutics Reports Positive Topline Results from Phase 1 Driving Simulation Trial of GlyphAllo™ in Healthy Volunteers

Yahoo Finance · 2026-09-09

Seaport Therapeutics to Present at Citi’s 2026 Biopharma Back to School Conference and Participate in 21st Annual Wells Fargo Healthcare Conference

Yahoo Finance · 2026-08-31

Why Bristol Myers, Johnson & Johnson and More Are Watching Seaport After IPO

Informational purposes only, not investment advice.